Last reviewed · How we verify
NI-03
At a glance
| Generic name | NI-03 |
|---|---|
| Sponsor | Kangen Pharmaceuticals, Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |